| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
62,894,000 |
| Market
Cap: |
2.62(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.61 - $51.88 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
223,855 |
| Total Sell Value |
$0 |
$0 |
$0 |
$8,358,941 |
| Total People Sold |
0 |
0 |
0 |
6 |
| Total Sell Transactions |
0 |
0 |
0 |
8 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Penner Harry Jr |
Director |
– • – |
2009-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
|
- |
|
| Schaller Charles R |
Director |
– • – |
2009-12-02 |
4 |
B |
$4.68 |
$32,806 |
D/D |
7,000 |
4,600 |
2.39 |
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2009-11-30 |
4 |
B |
$4.41 |
$4,408 |
D/D |
1,000 |
1,000 |
2.66 |
- |
|
| Ellberger Larry |
Director |
– • – |
2009-11-30 |
4 |
B |
$4.46 |
$22,361 |
D/D |
5,000 |
1,400 |
2.39 |
- |
|
| Ellberger Larry |
Director |
– • – |
2009-11-30 |
4 |
B |
$4.50 |
$45,024 |
D/D |
10,000 |
2,400 |
2.39 |
- |
|
| Schaller Charles R |
Director |
– • – |
2009-11-10 |
4 |
B |
$5.15 |
$51,555 |
D/D |
10,000 |
9,099 |
2.39 |
- |
|
| Marucci Anthony S |
President & CEO |
• – – |
2009-11-09 |
4 |
B |
$5.08 |
$50,974 |
D/D |
10,000 |
5,000 |
2.74 |
- |
|
| Shannon Timothy M |
Director |
– • – |
2009-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
66,212 |
|
- |
|
| Medarex Inc |
10% Owner |
– – • |
2009-06-24 |
4 |
S |
$7.15 |
$14,300,000 |
D/D |
(2,000,000) |
2,960,848 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
7,759 |
|
- |
|
| Newbold Ronald C |
Sr. VP, Business Dev. |
• – – |
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
5,868 |
|
- |
|
| Keler Tibor |
Sr. VP & CSO |
• – – |
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
5,868 |
|
- |
|
| Davis Thomas Andrew |
Sr. VP & CMO |
• – – |
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
5,868 |
|
- |
|
| Marucci Anthony S |
President & CEO |
• – – |
2009-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,868 |
5,868 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2009-01-02 |
4 |
A |
$6.73 |
$673 |
D/D |
100 |
100 |
|
- |
|
| Schaller Charles R |
Director |
– • – |
2008-11-13 |
4 |
B |
$6.11 |
$18,330 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| Parekh Rajesh R |
Director |
– • – |
2008-09-10 |
4 |
S |
$11.00 |
$23,947 |
I/I |
(2,178) |
0 |
|
- |
|
| Parekh Rajesh R |
Director |
– • – |
2008-09-09 |
4 |
S |
$11.05 |
$284,823 |
I/I |
(25,770) |
2,178 |
|
- |
|
| Parekh Rajesh R |
Director |
– • – |
2008-09-08 |
4 |
S |
$11.37 |
$321,512 |
I/I |
(28,275) |
27,948 |
|
- |
|
| Medarex Inc |
10% Owner |
– – • |
2008-06-23 |
4 |
S |
$12.35 |
$4,343,384 |
D/D |
(351,691) |
4,960,848 |
|
- |
|
| Lorantis Holdings Ltd |
10% Owner |
– – • |
2008-04-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,811,147) |
0 |
|
- |
|
| Lorantis Holdings Ltd |
10% Owner |
– – • |
2008-03-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,811,147 |
|
- |
|
| Parekh Rajesh R |
Director |
– • – |
2008-03-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,223 |
|
- |
|
| Medarex Inc |
10% Owner |
– – • |
2008-03-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,312,539 |
|
- |
|
| Freeman Paula R |
Sr.Dir.Human Resources |
– – – |
2008-01-02 |
4 |
A |
$0.43 |
$213 |
D/D |
500 |
2,955 |
|
- |
|
240 Records found
|
|
Page 8 of 10 |
|
|
0.91 (2.14%) 
